PHC Corporation, Biomedical Division

Product variability from biopharmaceutical manufacturing to storage can significantly impact the safety and efficacy of batch-to-batch products during clinical use.

Making an effective vaccine faces obstacles which depend on a complete line-up of pharmaceutical-grade refrigerators and freezers to maintain the necessary conditions.

As biological products are being investigated as treatment modalities, measures to ensure safety and quality from microbiological contamination becomes imperative.

Assuring sample integrity and security in the biopharmaceutical workflow process is important to establishing standards that guarantee proper sample security.

From starting considerations to crucial factors, learn what matters most and what to be mindful of when selecting an ultra-low temperature freezer for your laboratory.

Assuring sample integrity and security in the biopharmaceutical workflow process is important to establishing standards that guarantee proper sample security.

Product variability from biopharmaceutical manufacturing to storage can significantly impact the safety and efficacy of batch-to-batch products during clinical use.

A testimonial by Hubrecht Organoid Technology in Netherlands. An organoid research facility with an ultimate goal of regenerative medicine and cell therapy.

Making an effective vaccine faces obstacles which depend on a complete line-up of pharmaceutical-grade refrigerators and freezers to maintain the necessary conditions.

Pressure for innovative products is becoming greater for pharmaceutical companies as they spend a significant amount on R&D and ways to achieve ROI in biopharma labs.

A testimonial from The National Center for Global Health and Medicine BioBank in Japan, a biobank to help develop leading next generation medicine and drugs.

A testimonial by The Inserm Unit, Institute of Regenerative Medicine Biotherapy (IRMB) in France, a facility dedicated to stem cell research and immunotherapy.

How 50 years of R&D and customer collaboration have contributed in the manufacturing of microbiological incubators to meet emerging applications in biopharma industry.

As biological products are being investigated as treatment modalities, measures to ensure safety and quality from microbiological contamination becomes imperative.

The pressure for innovative products is becoming greater for pharmaceutical companies as they spend a significant amount on R&D in all stages of clinical trials. Thus, optimizing efficiency becomes imperative.

As the biopharmaceutical industry gains momentum and biological products are being heavily investigated as treatment modalities, measures are needed throughout to ensure their overall safety and quality from microbiological contamination.

The changes during biopharmaceutical manufacturing, processing and storage can impact the safety and efficacy of products during clinical use. Controlling such product variability is a challenge to maintaining batch-to-batch consistency.

Assuring sample integrity and security during the development, manufacturing, and supply of biopharmaceuticals is one of the most important aspects leading to establishing standards that guarantee proper sample security.